Context: The authors of this article are all affiliated with Partners in Health, an organization
that works to provide medical care in a number of countries, including the United States and …

Vaccination policies have shifted dramatically during COVID-19 with the rapid emergence of
population-wide vaccine mandates, domestic vaccine passports and differential restrictions …

The continuing spread of drug-resistant tuberculosis (TB) is one of the most urgent and
difficult challenges facing global TB control. Patients who are infected with strains resistant …

Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta …

Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs …

A meta-analysis for response to treatment was undertaken using individual data of multidrug-
resistant tuberculosis (MDR-TB)(resistance to isoniazid and rifampicin) patients from 26 …

Mycobacterium tuberculosis has been a major cause of human disease for centuries. This
article discusses the development of active drug therapy and the emergence and …

Background Multidrug-resistant tuberculosis threatens to reverse recent reductions in global
tuberculosis incidence. Although children younger than 15 years constitute more than 25 …

The broadest pattern of tuberculosis (TB) drug resistance for which a consensus definition
exists is extensively drug-resistant (XDR)-TB. It is not known if additional drug resistance …